Download presentation
Presentation is loading. Please wait.
1
Volume 5, Issue 1, Pages 31-40 (January 2018)
AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single- blind, randomised controlled trial Prof Tom KJ Craig, PhD, Mar Rus-Calafell, PhD, Thomas Ward, DClinPsy, Prof Julian P Leff, FRCPsych, Prof Mark Huckvale, PhD, Elizabeth Howarth, PhD, Prof Richard Emsley, PhD, Prof Philippa A Garety, PhD The Lancet Psychiatry Volume 5, Issue 1, Pages (January 2018) DOI: /S (17) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
2
Figure 1 Trial profile Numbers lost to follow-up are cumulative in relation to the total allocated at the start of the study. The Lancet Psychiatry 2018 5, 31-40DOI: ( /S (17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
3
Figure 2 Week 12 effect estimates and 95% CIs
Forest plot shows standardised Cohen's d effect sizes for AVATAR versus supportive counselling. Positive effect favours AVATAR therapy. All scales reversed, except for VAAS and MANSA. PSYRATS-AH= Psychotic Symptoms Rating Scales–Auditory Hallucinations. BAVQ-R=Beliefs About Voices Questionnaire. VAAS=Voice Acceptance and Action Scale. VPDS=Voice Power Differential Scale. DASS-21=Depression Anxiety and Stress Scale. PSYRATS–DEL=Psychotic Symptoms Rating Scales–Delusions. SAPS=Scale for Assessment of Positive Symptoms. SANS=Scale for Assessment of Negative Symptoms. MANSA=Manchester Quality of Life. MAP=Maudsley Addiction Profile. The Lancet Psychiatry 2018 5, 31-40DOI: ( /S (17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
4
Figure 3 PSYRATS–AH total, distress, and frequency scores
The Lancet Psychiatry 2018 5, 31-40DOI: ( /S (17) ) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.